NCT07607197Active, not recruitingPhase 1/2
IMMUNE RESET TO ALLOW ACCESS TO HLA-COMPATIBLE KIDNEY TRANSPLANTATION IN HYPERIMMUNIZED PATIENTS
Source: EU CTIS (euclinicaltrials.eu) · Last updated 28 Aug 2025
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 20 Sept 2023
- Start date
- 28 Aug 2025
- Lead sponsor
- Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
- Diseases
- Chronic kidney disease
- EU CT number
- 2023-506478-11-01
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 10
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron Coordinator of this site? Confirm its status | Barcelona | Spain | Active, not recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.